Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Nephros Q2 EPS $(0.04) Beats $(0.05) Estimate, Sales $3.54M Beat $3.11M Estimate

Author: Benzinga Newsdesk | August 09, 2023 04:20pm
Nephros (NASDAQ:NEPH) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.05) by 20 percent. This is a 66.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $3.54 million which beat the analyst consensus estimate of $3.11 million by 13.99 percent. This is a 22.92 percent increase over sales of $2.88 million the same period last year.

Posted In: NEPH


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist